Works matching IS 11795549 AND DT 2020 AND VI 14

Results: 31
    1
    2

    Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV.

    Published in:
    Clinical Medicine Insights: Oncology, 2020, v. 14, p. 1, doi. 10.1177/1179554920951358
    By:
    • Brueckl, Wolfgang M.;
    • Reck, Martin;
    • Rittmeyer, Achim;
    • Kollmeier, Jens;
    • Wesseler, Claas;
    • Wiest, Gunther H.;
    • Christopoulos, Petros;
    • Tufman, Amanda;
    • Hoffknecht, Petra;
    • Ulm, Bernhard;
    • Reich, Fabian;
    • Ficker, Joachim H.;
    • Laack, Eckart
    Publication type:
    Article
    3

    Results of the Austrian National Lung Cancer Audit.

    Published in:
    Clinical Medicine Insights: Oncology, 2020, v. 14, p. 1, doi. 10.1177/1179554920950548
    By:
    • Burghuber, Otto C.;
    • Kirchbacher, Klaus;
    • Mohn-Staudner, Andrea;
    • Hochmair, Maximilian;
    • Breyer, Marie-Kathrin;
    • Studnicka, Michael;
    • Mueller, Michael Rolf;
    • Feurstein, Petra;
    • Schrott, Andrea;
    • Lamprecht, Bernd;
    • Eckmayr, Josef;
    • Renner, Friedrich;
    • Bolitschek, Josef;
    • Pohl, Wolfgang;
    • Schenk, Peter;
    • Errhalt, Peter;
    • Cerkl, Peter;
    • Baumgartner, Bernhard;
    • Kneussl, Meinhard;
    • Hartl, Sylvia
    Publication type:
    Article
    4
    5
    6
    7
    8
    9

    Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV.

    Published in:
    Clinical Medicine Insights: Oncology, 2020, v. 14, p. 1, doi. 10.1177/1179554920951358
    By:
    • Brueckl, Wolfgang M;
    • Reck, Martin;
    • Rittmeyer, Achim;
    • Kollmeier, Jens;
    • Wesseler, Claas;
    • Wiest, Gunther H;
    • Christopoulos, Petros;
    • Tufman, Amanda;
    • Hoffknecht, Petra;
    • Ulm, Bernhard;
    • Reich, Fabian;
    • Ficker, Joachim H;
    • Laack, Eckart
    Publication type:
    Article
    10
    11

    Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality?

    Published in:
    Clinical Medicine Insights: Oncology, 2020, v. 14, p. 1, doi. 10.1177/1179554920946693
    By:
    • Dell'Aquila, Emanuela;
    • Zeppola, Tea;
    • Stellato, Marco;
    • Pantano, Francesco;
    • Scartozzi, Mario;
    • Madaudo, Cristina;
    • Pietrantonio, Filippo;
    • Cremolini, Chiara;
    • Aprile, Giuseppe;
    • Vincenzi, Bruno;
    • Moretto, Roberto;
    • Puzzoni, Marco;
    • Garattini, Silvio Ken;
    • Lobefaro, Riccardo;
    • Tonini, Giuseppe;
    • Santini, Daniele
    Publication type:
    Article
    12
    13
    14
    15
    16

    Evolution of Lung Cancer in the Context of Immunotherapy.

    Published in:
    Clinical Medicine Insights: Oncology, 2020, v. 14, p. 1, doi. 10.1177/1179554920979697
    By:
    • Sheng Yu;
    • Ruilin Wang;
    • Hong Tang;
    • Lili Wang;
    • Zhe Zhang;
    • Sen Yang;
    • Shuyue Jiao;
    • Xuan Wu;
    • Shuai Wang;
    • Mingyue Wang;
    • Cong Xu;
    • Qiming Wang;
    • Yufeng Wu
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24

    Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality?

    Published in:
    Clinical Medicine Insights: Oncology, 2020, v. 14, p. 1, doi. 10.1177/1179554920946693
    By:
    • Dell'Aquila, Emanuela;
    • Zeppola, Tea;
    • Stellato, Marco;
    • Pantano, Francesco;
    • Scartozzi, Mario;
    • Madaudo, Cristina;
    • Pietrantonio, Filippo;
    • Cremolini, Chiara;
    • Aprile, Giuseppe;
    • Vincenzi, Bruno;
    • Moretto, Roberto;
    • Puzzoni, Marco;
    • Garattini, Silvio Ken;
    • Lobefaro, Riccardo;
    • Tonini, Giuseppe;
    • Santini, Daniele
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31